Cisplatin, methotrexate and mitoxantrone in patients with metastatic or advanced urothelial cancer.
Andersen
L J
LJ
Department of Oncology, Aarhus University Hospital, Denmark.
Sengeløv
L
L
Kamby
C
C
von der Maase
H
H
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage; D016896:Treatment Outcome; D014571:Urologic Neoplasms / Q000188:drug therapy* / Q000401:mortality
D008942:Mitoxantrone; D002945:Cisplatin; D008727:Methotrexate